Covered recipient · General Payments record
LYNN D REYMAN
Allopathic & Osteopathic Physicians Emergency Medicine
General Payments · PY2018–2024
$1,218.72
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.17 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $155.67 | 4 |
| Gilead Sciences, Inc. | $121.83 | 1 |
| Inari Medical, Inc. | $23.80 | 1 |
| Janssen Pharmaceuticals, Inc | $14.45 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940428 | CMS |
| ABBVIE INC. | $30.39 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940430 | CMS |
| ABBVIE INC. | $15.45 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940432 | CMS |
| ABBVIE INC. | $92.83 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940434 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.42 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117848485 | CMS |
| Gilead Sciences, Inc. | $121.83 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133737036 | CMS |
| Inari Medical, Inc. | $23.80 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140159389 | CMS |
| Janssen Pharmaceuticals, Inc | $14.45 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078092894 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.